Legal & General Group
ARCT icon

Legal & General Group’s Arcturus Therapeutics ARCT Stock Holding History

Legal & General Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Hold
2,304
– – ﹤0.01% 3213
2026
Q1 		$17.8K Sell
2,304
-198
-8% -$1.45K ﹤0.01% 3003
2025
Q4 		$15.3K Hold
2,502
– – ﹤0.01% 3123
2025
Q3 		$46.1K Hold
2,502
– – ﹤0.01% 2754
2025
Q2 		$32.6K Sell
2,502
-22,620
-90% -$267K ﹤0.01% 2823
2025
Q1 		$266K Buy
25,122
+975
+4% +$15.5K ﹤0.01% 2569
2024
Q4 		$410K Hold
24,147
– – ﹤0.01% 2531
2024
Q3 		$560K Buy
24,147
+823
+4% +$17.6K ﹤0.01% 2426
2024
Q2 		$568K Buy
23,324
+1,579
+7% +$47.9K ﹤0.01% 2380
2024
Q1 		$734K Buy
21,745
+732
+3% +$25.9K ﹤0.01% 2292
2023
Q4 		$663K Buy
21,013
+681
+3% +$16.2K ﹤0.01% 2353
2023
Q3 		$519K Sell
20,332
-28
-0.1% -$863 ﹤0.01% 2419
2023
Q2 		$584K Buy
20,360
+10,500
+106% +$286K ﹤0.01% 2413
2023
Q1 		$236K Buy
9,860
+484
+5% +$8.68K ﹤0.01% 2526
2022
Q4 		$159K Buy
9,376
+515
+6% +$8.98K ﹤0.01% 2695
2022
Q3 		$131K Sell
8,861
-5,010
-36% -$84.1K ﹤0.01% 2748
2022
Q2 		$218K Buy
13,871
+1,305
+10% +$25.6K ﹤0.01% 2594
2022
Q1 		$339K Hold
12,566
– – ﹤0.01% 2500
2021
Q4 		$465K Buy
12,566
+2,985
+31% +$122K ﹤0.01% 2437
2021
Q3 		$457K Buy
9,581
+4,155
+77% +$186K ﹤0.01% 2438
2021
Q2 		$184K Sell
5,426
-556
-9% -$18.8K ﹤0.01% 2553
2021
Q1 		$247K Sell
5,982
-63
-1% -$3.75K ﹤0.01% 2418
2020
Q4 		$262K Buy
6,045
+688
+13% +$46.6K ﹤0.01% 2369
2020
Q3 		$229K Sell
5,357
-234
-4% -$11.6K ﹤0.01% 2333
2020
Q2 		$262K Buy
+5,591
New +$193K ﹤0.01% 2305

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Legal & General Group's ARCT Position: Q2 2026 in Review

Legal & General Group held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 2,304 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Legal & General Group first reported a position in ARCT in Q2 2020 and has held it in 25 quarters since. The position peaked at $734K in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Legal & General Group held 2,304 shares of Arcturus Therapeutics worth $15.5K as of Q2 2026.
  • Legal & General Group left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3213 holding.
  • Legal & General Group first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Legal & General Group's Arcturus Therapeutics position peaked at $734K in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.